ID
31653
Description
Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen.; ODM derived from: https://clinicaltrials.gov/show/NCT01045109
Link
https://clinicaltrials.gov/show/NCT01045109
Keywords
Versions (1)
- 9/17/18 9/17/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
September 17, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT01045109
Eligibility Prostate Cancer NCT01045109
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Cancer Other | Exception Skin carcinoma
Data type
boolean
Alias
- UMLS CUI [1]
- C1707251
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0699893
Description
Sarcoidosis
Data type
boolean
Alias
- UMLS CUI [1]
- C0036202
Description
Vitamin D3 Supplementation High dose
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3265062
- UMLS CUI [1,2]
- C0242297
- UMLS CUI [1,3]
- C0444956
Description
Hypercalcemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0020437
Description
Lithium
Data type
boolean
Alias
- UMLS CUI [1]
- C0023870
Similar models
Eligibility Prostate Cancer NCT01045109
- StudyEvent: Eligibility
C1282907 (UMLS CUI [1,2])
C0733511 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0202178 (UMLS CUI [2])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C0242297 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,3])